Related changes

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 17:20, 19 May 2024

List of abbreviations:

N: This edit created a new page (also see list of new pages)
m: This is a minor edit
b: This edit was performed by a bot
(±123): The page size changed by this number of bytes

19 May 2024

			m 01:07		Diffuse large B-cell lymphoma‎‎ 2 changes history +66‎ [Jwarner‎ (2×)]
			m		01:07 (cur \| prev) +21‎ Jwarner talk contribs →‎R-ESHAP {{#subobject:7794d\|Regimen=1}}
			m		01:05 (cur \| prev) +45‎ Jwarner talk contribs →‎Regimen {{#subobject:b6038c\|Variant=1}}

m 00:51

Head and neck cancer‎ diffhist +21‎ Jwarner talk contribs →‎Regimen variant #7, 100/3000 x 2 {{#subobject:dd2jgu|Variant=1}}

m 00:38

Mantle cell lymphoma‎ diffhist +17‎ Jwarner talk contribs →‎Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}}

18 May 2024

			m 11:56		HIV-associated lymphoma‎‎ 2 changes history +269‎ [Jwarner‎ (2×)]
			m		11:56 (cur \| prev) +180‎ Jwarner talk contribs
			m		11:52 (cur \| prev) +89‎ Jwarner talk contribs →‎CVP {{#subobject:1a817a\|Regimen=1}}

m 11:50

Acute myeloid leukemia‎ diffhist +292‎ Jwarner talk contribs →‎CLAG {{#subobject:702383|Regimen=1}}

			m 01:16		Acute promyelocytic leukemia‎‎ 3 changes history +206‎ [Jwarner‎ (3×)]
			m		01:16 (cur \| prev) +17‎ Jwarner talk contribs →‎ATRA monotherapy {{#subobject:45c33c\|Regimen=1}}
			m		01:13 (cur \| prev) +94‎ Jwarner talk contribs
			m		01:12 (cur \| prev) +95‎ Jwarner talk contribs →‎Regimen variant #3, 0.3/45 {{#subobject:e391b9\|Variant=1}}

m 01:03

Myelodysplastic syndrome‎ diffhist +412‎ Jwarner talk contribs

17 May 2024

18:50

Small cell lung cancer‎ diffhist +1,494‎ Jwarner talk contribs →‎Temozolomide monotherapy {{#subobject:693cf4|Regimen=1}}

m 18:28

Follicular lymphoma‎ diffhist +636‎ Jwarner talk contribs

m 18:26

Primary mediastinal B-cell lymphoma‎ diffhist +469‎ Jwarner talk contribs

m 18:25

Transformed lymphoma‎ diffhist +468‎ Jwarner talk contribs

m 18:25

Diffuse large B-cell lymphoma‎ diffhist +468‎ Jwarner talk contribs →‎References

			16:39		Prostate cancer‎‎ 8 changes history +4,033‎ [Jwarner‎ (8×)]
			m		16:39 (cur \| prev) -46‎ Jwarner talk contribs
			m		16:35 (cur \| prev) +4‎ Jwarner talk contribs →‎ADT {{#subobject:6e0da9\|Regimen=1}}
			m		16:34 (cur \| prev) -56‎ Jwarner talk contribs →‎ADT {{#subobject:8ab01b\|Regimen=1}}
			m		16:33 (cur \| prev) +262‎ Jwarner talk contribs
			m		16:26 (cur \| prev) -1,824‎ Jwarner talk contribs
					15:47 (cur \| prev) +5,689‎ Jwarner talk contribs →‎ADT {{#subobject:6e0da9\|Regimen=1}}
			m		15:27 (cur \| prev) +1‎ Jwarner talk contribs →‎Hormonal therapy for metastatic or locally advanced disease
			m		15:26 (cur \| prev) +3‎ Jwarner talk contribs →‎ADT {{#subobject:68ajcbz\|Regimen=1}}

			m 16:21		Breast cancer‎‎ 2 changes history -12‎ [Jwarner‎ (2×)]
			m		16:21 (cur \| prev) +5‎ Jwarner talk contribs
			m		16:15 (cur \| prev) -17‎ Jwarner talk contribs

m 15:54

Acute myeloid leukemia‎ diffhist +698‎ Jwarner talk contribs →‎References

16 May 2024

m 10:55

Non-small cell lung cancer‎ diffhist -80‎ Jwarner talk contribs →‎References

			m 00:45		Venous thromboembolism‎‎ 2 changes history -6,404‎ [Jwarner‎ (2×)]
			m		00:45 (cur \| prev) -6,662‎ Jwarner talk contribs →‎VTE primary prophylaxis
			m		00:42 (cur \| prev) +258‎ Jwarner talk contribs

			m 00:39		Follicular lymphoma‎‎ 11 changes history -23,293‎ [Jwarner‎ (11×)]
			m		00:39 (cur \| prev) -6,881‎ Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
			m		00:37 (cur \| prev) +105‎ Jwarner talk contribs →‎Relapsed or refractory, randomized data
			m		00:36 (cur \| prev) -1,395‎ Jwarner talk contribs →‎Maintenance after first-line therapy
			m		00:34 (cur \| prev) -12,670‎ Jwarner talk contribs →‎Consolidation after first-line therapy
			m		00:31 (cur \| prev) +35‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, non-randomized or retrospective data
			m		00:31 (cur \| prev) +4,108‎ Jwarner talk contribs →‎Rituximab and hyaluronidase monotherapy {{#subobject:hfn369\|Regimen=1}}
			m		00:31 (cur \| prev) -3,990‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, randomized data
			m		00:29 (cur \| prev) +105‎ Jwarner talk contribs →‎Early disease, definitive therapy
			m		00:26 (cur \| prev) -2,859‎ Jwarner talk contribs →‎Early disease, adjuvant therapy
			m		00:25 (cur \| prev) +29‎ Jwarner talk contribs
			m		00:24 (cur \| prev) +120‎ Jwarner talk contribs

			m 00:22		Chronic lymphocytic leukemia‎‎ 5 changes history -14,905‎ [Jwarner‎ (5×)]
			m		00:22 (cur \| prev) -4,585‎ Jwarner talk contribs →‎Consolidation and/or maintenance after subsequent lines of therapy
			m		00:19 (cur \| prev) -10,562‎ Jwarner talk contribs →‎Consolidation and/or maintenance after first-line therapy
			m		00:16 (cur \| prev) +42‎ Jwarner talk contribs →‎First-line therapy, non-randomized or retrospective data
			m		00:15 (cur \| prev) +42‎ Jwarner talk contribs →‎First-line therapy, randomized data
			m		00:09 (cur \| prev) +158‎ Jwarner talk contribs

m 00:00

Mantle cell lymphoma‎ diffhist -33‎ Jwarner talk contribs →‎First-line therapy, non-randomized or retrospective data

15 May 2024

			m 23:45		Paroxysmal nocturnal hemoglobinuria‎‎ 2 changes history -1,054‎ [Jwarner‎ (2×)]
			m		23:45 (cur \| prev) +51‎ Jwarner talk contribs
			m		23:42 (cur \| prev) -1,105‎ Jwarner talk contribs

m 23:31

Essential thrombocythemia‎ diffhist +41‎ Jwarner talk contribs

Namespace:	Invert selection Associated namespace
Tag filter:
Page name:	Show changes to pages linked to the given page instead

			m 01:16		Acute promyelocytic leukemia‎‎ 3 changes history +206‎ [Jwarner‎ (3×)]
			m		01:16 (cur \| prev) +17‎ Jwarner talk contribs →‎ATRA monotherapy {{#subobject:45c33c\|Regimen=1}}
			m		01:13 (cur \| prev) +94‎ Jwarner talk contribs
			m		01:12 (cur \| prev) +95‎ Jwarner talk contribs →‎Regimen variant #3, 0.3/45 {{#subobject:e391b9\|Variant=1}}

			16:39		Prostate cancer‎‎ 8 changes history +4,033‎ [Jwarner‎ (8×)]
			m		16:39 (cur \| prev) -46‎ Jwarner talk contribs
			m		16:35 (cur \| prev) +4‎ Jwarner talk contribs →‎ADT {{#subobject:6e0da9\|Regimen=1}}
			m		16:34 (cur \| prev) -56‎ Jwarner talk contribs →‎ADT {{#subobject:8ab01b\|Regimen=1}}
			m		16:33 (cur \| prev) +262‎ Jwarner talk contribs
			m		16:26 (cur \| prev) -1,824‎ Jwarner talk contribs
					15:47 (cur \| prev) +5,689‎ Jwarner talk contribs →‎ADT {{#subobject:6e0da9\|Regimen=1}}
			m		15:27 (cur \| prev) +1‎ Jwarner talk contribs →‎Hormonal therapy for metastatic or locally advanced disease
			m		15:26 (cur \| prev) +3‎ Jwarner talk contribs →‎ADT {{#subobject:68ajcbz\|Regimen=1}}

			m 00:39		Follicular lymphoma‎‎ 11 changes history -23,293‎ [Jwarner‎ (11×)]
			m		00:39 (cur \| prev) -6,881‎ Jwarner talk contribs →‎Consolidation after subsequent lines of therapy
			m		00:37 (cur \| prev) +105‎ Jwarner talk contribs →‎Relapsed or refractory, randomized data
			m		00:36 (cur \| prev) -1,395‎ Jwarner talk contribs →‎Maintenance after first-line therapy
			m		00:34 (cur \| prev) -12,670‎ Jwarner talk contribs →‎Consolidation after first-line therapy
			m		00:31 (cur \| prev) +35‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, non-randomized or retrospective data
			m		00:31 (cur \| prev) +4,108‎ Jwarner talk contribs →‎Rituximab and hyaluronidase monotherapy {{#subobject:hfn369\|Regimen=1}}
			m		00:31 (cur \| prev) -3,990‎ Jwarner talk contribs →‎Advanced disease, first-line therapy, randomized data
			m		00:29 (cur \| prev) +105‎ Jwarner talk contribs →‎Early disease, definitive therapy
			m		00:26 (cur \| prev) -2,859‎ Jwarner talk contribs →‎Early disease, adjuvant therapy
			m		00:25 (cur \| prev) +29‎ Jwarner talk contribs
			m		00:24 (cur \| prev) +120‎ Jwarner talk contribs

			m 00:22		Chronic lymphocytic leukemia‎‎ 5 changes history -14,905‎ [Jwarner‎ (5×)]
			m		00:22 (cur \| prev) -4,585‎ Jwarner talk contribs →‎Consolidation and/or maintenance after subsequent lines of therapy
			m		00:19 (cur \| prev) -10,562‎ Jwarner talk contribs →‎Consolidation and/or maintenance after first-line therapy
			m		00:16 (cur \| prev) +42‎ Jwarner talk contribs →‎First-line therapy, non-randomized or retrospective data
			m		00:15 (cur \| prev) +42‎ Jwarner talk contribs →‎First-line therapy, randomized data
			m		00:09 (cur \| prev) +158‎ Jwarner talk contribs